Shorla Phar­ma scores an ex­pe­dit­ed re­view for its mys­tery can­di­date to treat T-cell ma­lig­nan­cies

Since launch­ing Shorla Phar­ma three years ago to de­sign bet­ter ver­sions of ex­ist­ing can­cer drugs, co-founders Sharon Cun­ning­ham and Or­laith Ryan have of­fered scarce de­tails …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER